Stockscreener 앱 받기
1.83
4.19%
-0.08
시간 외 거래:
1.85
0.02
+1.09%
전일 마감가:
$1.91
열려 있는:
$1.9
하루 거래량:
510.56K
Relative Volume:
10.89
시가총액:
$88.40M
수익:
-
순이익/손실:
$-90.97M
주가수익비율:
-0.9715
EPS:
-1.8837
순현금흐름:
$-32.83M
1주 성능:
-6.15%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.80
$1.90
1주일 범위
$1.80
$2.06
52주 변동 폭
$1.80
$2.0901
Filana Therapeutics Inc Stock (FLNA) Company Profile
명칭
Filana Therapeutics Inc
전화
512-501-2444
주소
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN
Compare FLNA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FLNA
Filana Therapeutics Inc
|
1.83 | 92.27M | 0 | -90.97M | -32.83M | -1.8837 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Filana Therapeutics Inc Stock (FLNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-27 | 개시 | B. Riley Securities | Buy |
| 2021-02-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-09-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-01-10 | 재확인 | Maxim Group | Buy |
모두보기
Filana Therapeutics Inc 주식(FLNA)의 최신 뉴스
Changes in working capital of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Stock Price, News & Analysis - Stock Titan
Non-controlling/minority interest of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Taxes of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Technical Analysis & Stock Price Forecast - Intellectia AI
Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Cassava Sciences, Inc. Class Action: The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | PX91 | US14817C1071 - marketscreener.com
Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Filana Therapeutics Inc (FLNA-Q) Profile - The Globe and Mail
Filana Therapeutics Inc FLNA-Q Earnings - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Statistics - The Globe and Mail
Net income before discontinued operations of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc. Statistics – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Financial Data Forecasts Estimates and Expectations | SAVA * | US14817C1071 - marketscreener.com
Total liabilities of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total liabilities & shareholders' equities of Filana Therapeutics, Inc. – BOATS:FLNA - TradingView
Return on assets % of Filana Therapeutics, Inc. – BOATS:FLNA - TradingView
After tax other income/expense of Filana Therapeutics, Inc. – BOATS:FLNA - TradingView
FLNA Forecast — Price Target — Prediction for 2027 - TradingView
Filana Therapeutics, Inc. Income Statement – BOATS:FLNA - TradingView
Filana Therapeutics, Inc.: Top Mutual Funds Holders | FLNA | US14817C1071 - marketscreener.com
Filana Therapeutics, Inc.: Revenue and Earnings Analysts Forecasts Revisions | FLNA | US14817C1071 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
FLNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Net debt of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA PE Ratio & Valuation, Is FLNA Overvalued - Intellectia AI
Filana Therapeutics (NASDAQ: SAVA) pivots to TSC epilepsy amid FDA clinical hold - Stock Titan
Free cash flow of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Cash from investing activities of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
CapEx per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Enterprise value of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Return on equity % of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Tangible book value per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Price to sales ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Asset turnover of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Enterprise value to EBITDA ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Operating cash flow per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Long term debt to total assets ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Working capital per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Operating income of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total debt of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year - TipRanks
Operating margin % of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Diluted earnings per share (diluted EPS) of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total equity of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Revenue per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Diluted shares outstanding of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total revenue of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics Inc (FLNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):